Trial intelligence / Profile preview

Vitamin D3 for Depression in Women with Type 2 Diabetes

NCT01904032Phase 2Completed

Sponsor
Loyola University Chicago
Start
Nov 2013
Primary completion
Nov 2017
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

A Phase 2 trial of vitamin d in major depressive disorder (MDD), hypertension (HTN), sponsored by Loyola University Chicago. Started Nov 2013; status: completed.

02

Drugs

vitamin d
03

Conditions

major depressive disorder (MDD)hypertension (HTN)

Beyond the preview

Go deeper on NCT01904032.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01904032.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call